跳至主要内容
临床试验/ACTRN12610000831088
ACTRN12610000831088已完成未知

Femoral Artery closure using the Cardiva Vascular Closure System (VCS) to reduce time to hemostasis and reduce time to ambulation

Cardiva Medical, Inc.0 个研究点目标入组 60 人开始时间: 2010年10月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Clinically indicated for an diagnostic or interventional endovascular procedure anticipated to employ common femoral artery access using a modified Seldinger technique and a 6F or 7F introducer sheath

排除标准

  • Key PRE-OPERATIVE EXCLUSION CRITERIA
  • 1.Septicemia or a cutaneous/subcutaneous groin infection
  • 2.Ipsilateral femoral arteriotomy within the previous 30 days
  • 3.Planned arterial access at the same site within the next 90 days
  • 4.Extreme morbid obesity (Body mass index (BMI) greater than 45 kg/m2) or underweight (BMI less than 22 kg/m2)
  • 5.Femoral artery diameter less than 6 mm
  • 6.Difficulty achieving arterial access and/or inserting the introducer sheath at the onset of the procedure (e.g., multiple stick attempts)
  • 7.Fluoroscopically visible calcium, atherosclerotic disease, or stent within 1 cm of the puncture site

研究者

相似试验